Effects of Hydrogen Sulfide-releasing l-DOPA Derivatives on Glial Activation

Oxidative stress induces a reversible flux of cysteine from tissues to blood in vivo in the rat

(2009) Daniela Giustarini et al.   FEBS Journal

Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation

(2009) Moonhee Lee et al.   GLIA

Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia

(2009) Stefano Zoccolella et al.   MOVEMENT DISORDERS

Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide

(2009) Moonhee Lee et al.   NEUROBIOLOGY OF AGING

Nonsteroidal Anti-Inflammatory Drugs in Experimental Parkinsonian Models and Parkinsons Disease

(2008) Masato Asanuma et al.   CURRENT PHARMACEUTICAL DESIGN

Molecular mechanisms of L-DOPA-induced dyskinesia

(2008) Peter Jenner   NATURE REVIEWS NEUROSCIENCE

H2S as a Physiologic Vasorelaxant: Hypertension in Mice with Deletion of Cystathionine  -Lyase

(2008) G. Yang et al.   SCIENCE

Simultaneous determination of serum concentrations of levodopa, dopamine, 3-O-methyldopa and α-methyldopa by HPLC

(2007) Chiara Muzzi et al.   BIOMEDICINE & PHARMACOTHERAPY

Inflammation as a causative factor in the aetiology of Parkinson's disease

(2007) P S Whitton   BRITISH JOURNAL OF PHARMACOLOGY

Glial reactions in Parkinson's disease

(2007) Patrick L. McGeer et al.   MOVEMENT DISORDERS

Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk

(2007) Karen M. Powers et al.   MOVEMENT DISORDERS